SCHEMBL2809048

SCHEMBL2809048

COc1ccccc1OC=C(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
POLB P06746 1/20 0.47
CA12 O43570 3/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
CA7 P43166 2/20 0.46
CA14 Q9ULX7 2/20 0.46
CA4 P22748 1/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 1/20 0.46
LMNA P02545 5/20 0.45
KDM4E B2RXH2 3/20 0.45
AKR1C3 P42330 1/20 0.44
APEX1 P27695 1/20 0.44
PKM P14618 1/20 0.43
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
TFEB P19484 1/20 0.42
NFE2L2 Q16236 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809046 1.00 SMN1; SMN2 (0.47) SMN1; SMN2POLBCA12CA1CA2
SCHEMBL2812445 0.84 CA12 (0.47) CA12CA1CA2CA9CA7
SCHEMBL2812447 0.84 CA12 (0.47) CA12CA1CA2CA9CA7
SCHEMBL6207378 0.83 POLB (0.49) SMN1; SMN2POLBCA12CA1CA2
SCHEMBL27374622 0.82 AKR1C3 (0.44) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL2811159 0.82 AKR1C3 (0.44) SMN1; SMN2POLBHTTKDM4EAKR1C3
SCHEMBL2811157 0.82 AKR1C3 (0.44) SMN1; SMN2POLBHTTKDM4EAKR1C3
SCHEMBL2809083 0.81 NPSR1 (0.48) SMN1; SMN2KMT2AHTTLMNAKDM4E
SCHEMBL2809079 0.81 NPSR1 (0.48) SMN1; SMN2KMT2AHTTLMNAKDM4E
SCHEMBL2811515 0.80 CA12 (0.52) SMN1; SMN2POLBCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 SMN1; SMN2 1135/4885POLB 4283/4885CA12 3493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.